Zentalis Pharmaceuticals, Inc. (ZNTL)
3.72
-0.04
(-1.06%)
USD |
NASDAQ |
Sep 01, 15:49
Zentalis Pharmaceuticals Cash from Operations (TTM) : -128.10M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -128.10M |
| March 31, 2026 | -125.57M |
| December 31, 2025 | -125.25M |
| September 30, 2025 | -134.01M |
| June 30, 2025 | -151.09M |
| March 31, 2025 | -151.52M |
| December 31, 2024 | -170.86M |
| September 30, 2024 | -171.76M |
| June 30, 2024 | -166.38M |
| March 31, 2024 | -210.51M |
| December 31, 2023 | -207.82M |
| September 30, 2023 | -204.55M |
| June 30, 2023 | -199.09M |
| March 31, 2023 | -162.84M |
| Date | Value |
|---|---|
| December 31, 2022 | -163.75M |
| September 30, 2022 | -163.44M |
| June 30, 2022 | -163.73M |
| March 31, 2022 | -166.82M |
| December 31, 2021 | -154.09M |
| September 30, 2021 | -144.43M |
| June 30, 2021 | -131.50M |
| March 31, 2021 | -107.42M |
| December 31, 2020 | -86.82M |
| September 30, 2020 | -72.66M |
| June 30, 2020 | -62.08M |
| March 31, 2020 | -47.01M |
| December 31, 2019 | -39.14M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| ARS Pharmaceuticals, Inc. | -196.40M |
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| Anika Therapeutics, Inc. | 5.977M |
| Savara, Inc. | -110.38M |